Clinical Evidence
254 results
HDx therapy enabled by Theranova
Middle molecule elimination in expanded haemodialysis: only convective transport?
HDx therapy enabled by Theranova
Middle molecules removal and anticoagulation in hemodialysis with a medium cut off membrane: preliminary data from a monocentric trial
HDx therapy enabled by Theranova
Most recently developed polyester polymer alloy dialyzer: A new medium cut-off membrane?.
HD
Multicenter, prospective, randomised, crossover trial to demonstrate the benefits of hemodialysis without acetate (with citrate): ABC-treat study - Sequera et al.
HDx therapy enabled by Theranova
New medium cut-off membrane vs online hemodiafiltration in clearance of middle molecules. Preliminary results from our centre
PD
Novel applications of remote patient management to improve outcomes in peritoneal dialysis
HDx therapy enabled by Theranova
On the balance between albumin loss and removal of middle molecules in dialyzers
HDx therapy enabled by Theranova
On the balance between albumin loss and removal of middle molecules in dialyzers
HDx therapy enabled by Theranova
On the Removal of Middle Molecules and Albumin Loss: An Ex Vivo Evaluation of Commercial Dialyzers
PD
Patient Expectations and Experiences of remote monitoring for chronic diseases: Systematic review and thematic synthesis of qualitative studies – Walker R, et. al.
PD
PD Cycler With 2-Way Remote Management Technology Reveals Patient Adherence Patterns to Dialysis - Firanek CA, et al.
HDx therapy enabled by Theranova
Performance of hemodialysis with novel medium cut-off dialyzers - Kirsch AH, et al.
Vantive is a trademark of Vantive Health LLC or its affiliates.